Home

Download

Statistics

Landscape

Help

Contact

	Gene summary
	Datasets with differential expression of this gene
	Expression of this gene in the resistant group across all datasets and cell types
	Significant ligand-receptor pairs related to this gene
	Known drug resistance mechanisms of this gene (This gene does not contain this module)
	MicroRNAs (miRNAs) regulating this gene
	Motifs and transcription factors (TFs) regulating this gene
	Acts as a transcription factor (This gene does not contain this module)
	Acts as a drug target

Gene: CD55

Summary for CD55

Gene information	Gene symbol	CD55
	Ensembl ID	ENSG00000196352
	Entrez ID	1604
	Gene name	CD55 molecule (Cromer blood group)
	Synonyms	CR\|CROM\|DAF\|TC
	Gene type	protein_coding
	UniProtAcc	NA

Top

Dataset with differentially expressed gene: CD55

Differentially expression genes between the resistant and sensitive groups. A positive avg_log2FC represents significantly high expression in the resistant group, while a negative avg_log2FC represents significantly low expression in the resistant group.

Dataset	Source	Tissue	Cancer type level1	Cancer type level2	Drug type	Regimen	Timepoint	Cell type	avg_log2FC	p_val_adj
GSE169246_PacBlood	patients	Peripheral blood mononuclear cells	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	paclitaxel	pre	cDCs	0.327925	1.29e-09
GSE169246_PacBlood	patients	Peripheral blood mononuclear cells	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	paclitaxel	pre	CD4+ T cells	0.387585	0.00e+00
GSE169246_PacBlood	patients	Peripheral blood mononuclear cells	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	paclitaxel	pre	B cells	0.476233	0.00e+00
GSE169246_PacTissue	patients	Tumor tissue	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Chemotherapy	paclitaxel	post	B cells	-0.739565	6.63e-23
GSE153697	patients	Bone marrow aspirate	Acute lymphoblastic leukemia	Relapsed B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	anti-CD19 CAR-T	NA	Malignant cells	-0.352445	2.25e-09
GSE169246_PacAteBlood	patients	Peripheral blood mononuclear cells	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	atezolizumab + paclitaxel	post	Mono/Macro	-0.266801	2.95e-31
GSE169246_PacAteTissue	patients	Tumor tissue	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	atezolizumab + paclitaxel	post	CD8+ T cells	0.4106	0.00e+00
GSE169246_PacAteTissue	patients	Tumor tissue	Breast cancer	Advanced triple-negative breast cancer (TNBC)	Immunotherapy	atezolizumab + paclitaxel	pre	Mono/Macro	-0.327408	2.27e-22
PMID34715028	patients	Tumor tissue	Kidney cancer	Clear cell renal cell carcinoma (ccRCC)	Immunotherapy	nivolumab	post	CD4+ T cells	-0.400573	2.62e-28
GSE207422_Sin	patients	Tumor tissue	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	post	Mono/Macro	-0.414416	3.00e-02
GSE207422_Sin	patients	Tumor tissue	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	sintilimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	post	B cells	0.323259	9.89e-06
GSE197268_Tisa-cel	patients	Peripheral blood mononuclear cells	Acute lymphoblastic leukemia	Large B-cell acute lymphoblastic leukemia (B-ALL)	Immunotherapy	tisa-cel (CAR-T)	pre	Mono/Macro	0.25486	3.01e-39
GSE207422_Tor	patients	Tumor tissue	Lung cancer	EGFR/ALK mutation negative non-small cell lung cancer (NSCLC)	Immunotherapy	toripalimab + carboplatin + (docetaxel or pemetrexed or emcitabine)	post	Malignant cells	0.534275	2.24e-21
GSE189460	patients	Bone marrow aspirate	Multiple myeloma	Multiple myeloma (MM)	Targeted therapy	bortezomib + melphalan + prednisolone	pre	Malignant cells	0.464539	0.00e+00
GSE161801_PI	patients	Bone marrow aspirate	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	carfilzomib + dexamethasone	pre	NK cells	-0.403356	3.86e-10
GSE139386	H3122 cell line	Cell line	Lung cancer	EML4-ALK fusion-positive non-small cell lung cancer (NSCLC)	Targeted therapy	ceritinib	NA	Malignant cells	1.1669	0.00e+00
GSE199333	patients	Bone marrow aspirate	Acute myeloid leukemia	Primary FLT3-ITD-mutated acute myeloid leukemia (AML)	Targeted therapy	gilteritinib	post	Malignant cells	-0.534863	0.00e+00
GSE131984_JQ1	SUM159 cell line	Cell line	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	JQ1	NA	Malignant cells	-0.317403	9.92e-16
GSE131984_JQ1Pac	SUM159 cell line	Cell line	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	JQ1 + paclitaxel	NA	Malignant cells	-0.523158	9.30e-27
GSE131984_JQ1Pal	SUM159 cell line	Cell line	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	JQ1 + palbociclib	NA	Malignant cells	-0.340741	2.32e-13
GSE131984_Pal	SUM159 cell line	Cell line	Breast cancer	Triple-negative breast cancer (TNBC)	Targeted therapy	palbociclib	NA	Malignant cells	-0.326255	9.95e-09
GSE161801_IMiD	patients	Bone marrow aspirate	Multiple myeloma	Refractory multiple myeloma (MM)	Targeted therapy	pomalidomide + dexamethasone OR lenalidomide + dexamethasone	pre	Malignant cells	0.311918	0.00e+00
GSE175716	PDX	Tumor tissue	Liver cancer	Advanced hepatocellular carcinoma	Targeted therapy	sorafenib	NA	Malignant cells	-0.988048	0.00e+00
GSE164897_VemCob	A375 cell line	Cell line	Melanoma	BRAFV600E-mutant melanoma	Targeted therapy	vemurafenib + combimetinib	NA	Malignant cells	-0.693184	0.00e+00
GSE164897_VemTra	A375 cell line	Cell line	Melanoma	B+E2:E57RAFV600E-mutant melanoma	Targeted therapy	vemurafenib + trametinib	NA	Malignant cells	-0.327653	0.00e+00

Top

Expression of CD55 in the resistant group across all datasets and cell types

Red dots represent significantly high expression in the resistant group, while blue dots represent significantly low expression in the resistant group. White dots represent that there is no significant difference in the expression of this gene between the resistant and sensitive groups. Blank represents that this cell type is not present in this dataset. (If the image exists, the user can click on it to enlarge it in a new window.)

Top

Significant ligand-receptor pairs related to CD55

This table shows the significant ligand-receptor pairs related to this gene across all datasets, timepoints and conditions. (Complete files can be downloaded from the download section.)

Gene symbol	Cell type with DEG	Interaction ID	Interacting pair	Gene A	Gene B	Integrin	Interacting cell type1	Interacting cell type2	Dataset	Timepoint	Condition
CD55	CD4+ T cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	CD4+ T cells	Mono/Macro	GSE169246_PacBlood	pre	resistant
CD55	CD4+ T cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	CD4+ T cells	NK cells	GSE169246_PacBlood	pre	resistant
CD55	B cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	B cells	CD4+ T cells	GSE169246_PacBlood	pre	resistant
CD55	B cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	B cells	CD8+ T cells	GSE169246_PacBlood	pre	resistant
CD55	B cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	B cells	Mono/Macro	GSE169246_PacBlood	pre	resistant
CD55	B cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	B cells	NK cells	GSE169246_PacBlood	pre	resistant
CD55	cDCs	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	cDCs	Mono/Macro	GSE169246_PacBlood	pre	resistant
CD55	cDCs	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	cDCs	NK cells	GSE169246_PacBlood	pre	resistant
CD55	CD4+ T cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	CD4+ T cells	CD8+ T cells	GSE169246_PacBlood	pre	sensitive
CD55	CD4+ T cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	CD4+ T cells	Mono/Macro	GSE169246_PacBlood	pre	sensitive
CD55	CD4+ T cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	CD4+ T cells	NK cells	GSE169246_PacBlood	pre	sensitive
CD55	B cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	B cells	CD8+ T cells	GSE169246_PacBlood	pre	sensitive
CD55	B cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	B cells	Mono/Macro	GSE169246_PacBlood	pre	sensitive
CD55	B cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	B cells	NK cells	GSE169246_PacBlood	pre	sensitive
CD55	cDCs	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	cDCs	Mono/Macro	GSE169246_PacBlood	pre	sensitive
CD55	B cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	B cells	B cells	GSE169246_PacTissue	post	resistant
CD55	B cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	B cells	CD4+ T cells	GSE169246_PacTissue	post	resistant
CD55	B cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	B cells	CD8+ T cells	GSE169246_PacTissue	post	resistant
CD55	B cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	B cells	Mono/Macro	GSE169246_PacTissue	post	resistant
CD55	B cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	B cells	NK cells	GSE169246_PacTissue	post	resistant
CD55	B cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	B cells	cDCs	GSE169246_PacTissue	post	resistant
CD55	B cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	B cells	pDCs	GSE169246_PacTissue	post	resistant
CD55	B cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	B cells	B cells	GSE169246_PacTissue	post	sensitive
CD55	B cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	B cells	CD4+ T cells	GSE169246_PacTissue	post	sensitive
CD55	B cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	B cells	CD8+ T cells	GSE169246_PacTissue	post	sensitive
CD55	B cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	B cells	Mono/Macro	GSE169246_PacTissue	post	sensitive
CD55	B cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	B cells	NK cells	GSE169246_PacTissue	post	sensitive
CD55	B cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	B cells	cDCs	GSE169246_PacTissue	post	sensitive
CD55	B cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	B cells	pDCs	GSE169246_PacTissue	post	sensitive
CD55	Malignant cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	Malignant cells	CD4+ T cells	GSE189460	pre	resistant
CD55	Malignant cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	Malignant cells	CD8+ T cells	GSE189460	pre	resistant
CD55	Malignant cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	Malignant cells	Mono/Macro	GSE189460	pre	resistant
CD55	Malignant cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	Malignant cells	NK cells	GSE189460	pre	resistant
CD55	Malignant cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	Malignant cells	cDCs	GSE189460	pre	resistant
CD55	Malignant cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	Malignant cells	pDCs	GSE189460	pre	resistant
CD55	Malignant cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	Mono/Macro	Malignant cells	GSE189460	pre	resistant
CD55	Malignant cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	Malignant cells	CD8+ T cells	GSE189460	pre	sensitive
CD55	Malignant cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	Malignant cells	Mono/Macro	GSE189460	pre	sensitive
CD55	Malignant cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	Malignant cells	NK cells	GSE189460	pre	sensitive
CD55	Malignant cells	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	Mono/Macro	Malignant cells	GSE189460	pre	sensitive
CD55	Mono/Macro	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	CD4+ T cells	Mono/Macro	GSE197268_Tisa-cel	pre	resistant
CD55	Mono/Macro	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	CD8+ T cells	Mono/Macro	GSE197268_Tisa-cel	pre	resistant
CD55	Mono/Macro	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	Mono/Macro	Mono/Macro	GSE197268_Tisa-cel	pre	resistant
CD55	Mono/Macro	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	Mono/Macro	NK cells	GSE197268_Tisa-cel	pre	resistant
CD55	Mono/Macro	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	NK cells	Mono/Macro	GSE197268_Tisa-cel	pre	resistant
CD55	Mono/Macro	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	CD4+ T cells	Mono/Macro	GSE197268_Tisa-cel	pre	sensitive
CD55	Mono/Macro	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	CD8+ T cells	Mono/Macro	GSE197268_Tisa-cel	pre	sensitive
CD55	Mono/Macro	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	Mono/Macro	Mono/Macro	GSE197268_Tisa-cel	pre	sensitive
CD55	Mono/Macro	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	Mono/Macro	NK cells	GSE197268_Tisa-cel	pre	sensitive
CD55	Mono/Macro	CPI-SS061A7E099	CD55_ADGRE5	CD55	ADGRE5	False	NK cells	Mono/Macro	GSE197268_Tisa-cel	pre	sensitive

Page: 1 2 3

Top

Known drug resistance mechanisms of this gene

This table shows the known drug resistance mechanisms of this gene. Clicking on this gene will link to another database that displays more drug resistance-related information.

Top

MicroRNAs (miRNA) regulating CD55

This table shows the miRNAs with a score of more than 80 regulating this gene. (Complete files can be downloaded from the download section.)

Gene symbol	miRNA	Score	GeneBank accession
CD55	hsa-let-7c-3p	93.5715	NM_001300902
CD55	hsa-miR-3658	92.8328	NM_001300903
CD55	hsa-miR-6760-3p	92.6958	NM_001300903
CD55	hsa-miR-3148	92.6674	NM_001300903
CD55	hsa-miR-5590-5p	92.5287	NM_001300903
CD55	hsa-miR-6891-5p	89.9847	NM_001300903
CD55	hsa-miR-12118	89.7056	NM_001300903
CD55	hsa-miR-3173-3p	89.7056	NM_001300903
CD55	hsa-miR-4778-3p	89.4817	NM_001300904
CD55	hsa-miR-4729	89.3193	NM_001300904
CD55	hsa-miR-627-3p	89.1861	NM_001300903
CD55	hsa-miR-6507-5p	88.514	NM_001300903
CD55	hsa-miR-6885-3p	87.5056	NM_001300903
CD55	hsa-miR-548av-5p	87.4775	NM_001300903
CD55	hsa-miR-548k	87.4775	NM_001300903
CD55	hsa-miR-4317	87.0633	NM_001300903
CD55	hsa-miR-8054	87.0101	NM_001300903
CD55	hsa-miR-338-5p	85.5282	NM_001300903
CD55	hsa-miR-766-5p	84.9202	NM_001300903
CD55	hsa-miR-4659b-3p	84.5624	NM_001300904
CD55	hsa-miR-4659a-3p	84.5624	NM_001300904
CD55	hsa-miR-4666a-5p	83.9732	NM_001300903
CD55	hsa-miR-676-5p	83.7848	NM_001300903
CD55	hsa-miR-1226-3p	83.3719	NM_001300903
CD55	hsa-miR-3065-5p	82.8809	NM_001300903
CD55	hsa-miR-12113	81.1953	NM_001300904
CD55	hsa-miR-3140-3p	81.1334	NM_001300903
CD55	hsa-miR-1284	80.681	NM_001300903

Page: 1

Top

Motifs and transcription factors (TFs) regulating CD55

This table shows the Motifs and transcription factors (TFs) regulating this gene. (Complete files can be downloaded from the download section.)

Gene symbol	motif	TF_highConf
CD55	taipale_tf_pairs__ATF4_TEF_RNMTGATGCAATN_CAP	ATF4; TEF (directAnnotation).
CD55	taipale_tf_pairs__ATF4_CEBPD_NGATGATGCAATNN_CAP	ATF4; CEBPD (directAnnotation).
CD55	metacluster_156.2	ATF3; ATF4; ATF4; ATF4; ATF4; ATF4; ATF4; CEBPG; CEBPG; DDIT3; MYC (directAnnotation). ATF4; ATF4; ATF4; CEBPG; DDIT3 (inferredBy_Orthology).
CD55	kznf__ZNF282_Imbeault2017_OM_RCADE	ZNF282 (directAnnotation).
CD55	taipale_tf_pairs__ATF4_CEBPB_NNATGAYGCAAYN_CAP	ATF4; CEBPB (directAnnotation).
CD55	kznf__ZNF25_Imbeault2017_OM_MEME	ZNF25 (directAnnotation).
CD55	taipale_cyt_meth__CREB1_NRTGACGTN_eDBD_repr	CREB1 (directAnnotation).
CD55	metacluster_111.3	ATF1; ATF3; CREB1; CREB1; CREB1; CREB1; CREB1; CREM; CREM; CREM; CREM; E4F1; E4F1 (directAnnotation). CREB1; CREB1; CREM; JDP2 (inferredBy_Orthology).
CD55	jaspar__MA0604.1	ATF1 (inferredBy_Orthology).
CD55	transfac_pro__M00691	ATF1 (directAnnotation).
CD55	jaspar__MA0039.4	KLF4 (directAnnotation).
CD55	transfac_pro__M04746	E2F1 (directAnnotation).
CD55	metacluster_163.1	KLF1; KLF1; KLF1; KLF1; KLF1; KLF1; KLF1; KLF10; KLF10; KLF12; KLF12; KLF12; KLF13; KLF16; KLF17; KLF2; KLF3; KLF3; KLF3; KLF3; KLF4; KLF4; KLF4; KLF4; KLF4; KLF5; KLF5; KLF5; KLF5; KLF6; KLF6; KLF6; KLF7; KLF9; KLF9; SALL4; SP1; ZNF148; ZNF148; ZNF526 (directAnnotation). EGR4; KLF1; KLF1; KLF12; KLF12; KLF12; KLF13; KLF14; KLF14; KLF14; KLF14; KLF14; KLF14; KLF16; KLF17; KLF17; KLF17; KLF17; KLF17; KLF18; KLF18; KLF18; KLF18; KLF18; KLF18; KLF2; KLF2; KLF3; KLF4; KLF4; KLF4; KLF4; KLF4; KLF4; KLF5; KLF5; KLF5; KLF6; KLF7; KLF7; KLF8; KLF8; KLF9; SP4; SP5; SP5; SP6; SP7; SP8; SP9; ZNF526 (inferredBy_Orthology).
CD55	transfac_pro__M04595	SALL2 (directAnnotation).
CD55	jaspar__MA1561.1	SOX12 (directAnnotation).
CD55	jaspar__MA1562.1	SOX14 (directAnnotation).
CD55	taipale_tf_pairs__SOX17_ACCGAACAAT_HT	SOX17 (directAnnotation).
CD55	transfac_pro__M06609	ZKSCAN4 (directAnnotation).
CD55	metacluster_135.10	MBD2; MBD2; MECP2; MECP2 (directAnnotation).
CD55	metacluster_144.3	ZNF704; ZNF704 (directAnnotation).
CD55	kznf__ZNF682_Isakova2017_SMiLE-seq	ZNF682 (directAnnotation).
CD55	metacluster_22.33	MAFK (inferredBy_Orthology).
CD55	taipale_cyt_meth__IRF6_ACCGAWACY_FL_meth	IRF6 (directAnnotation).
CD55	metacluster_22.32	NFE2L2 (directAnnotation).
CD55	metacluster_22.37	BACH1 (directAnnotation).
CD55	metacluster_22.1	MAFF (inferredBy_Orthology).
CD55	tfdimers__MD00535	FOXG1; FOXO1; TFAP4 (directAnnotation).
CD55	metacluster_79.2	ZNF436 (inferredBy_Orthology).
CD55	metacluster_22.19	NFE2 (directAnnotation).
CD55	metacluster_22.36	BACH2 (directAnnotation).
CD55	metacluster_22.20	MAFG (directAnnotation).
CD55	dbtfbs__ZSCAN30_HEK293_ENCSR768VNZ_merged_N1	ZSCAN30 (directAnnotation).
CD55	transfac_pro__M01088	DEAF1 (inferredBy_Orthology).
CD55	transfac_pro__M01973	PLAG1 (directAnnotation).
CD55	transfac_pro__M00514	ATF4 (directAnnotation).
CD55	jaspar__MA1708.1	ETV7 (directAnnotation).
CD55	taipale_tf_pairs__ETV2_FOXO6_RCCGGATGTTKWN_CAP	ETV2; FOXO6 (directAnnotation).
CD55	metacluster_174.3	MBD2; NFYA; NFYB; NFYC; PBX3 (directAnnotation).
CD55	taipale_tf_pairs__GCM1_ELF1_NRCCCRNNCGGAAGNN_CAP_repr	ELF1; GCM1 (directAnnotation).
CD55	taipale_tf_pairs__ETV5_EVX1_RSCGGWAATKR_CAP	ETV5; EVX1 (directAnnotation).
CD55	kznf__ZNF441_Imbeault2017_OM_RCADE	ZNF441 (directAnnotation).
CD55	taipale_tf_pairs__GCM1_FOXI1_RTMAACATRNGGGN_CAP_repr	FOXI1; GCM1 (directAnnotation).
CD55	transfac_pro__M06857	ZNF611 (directAnnotation).
CD55	taipale_tf_pairs__CUX1_TBX21_NTCACACMNNNATCRATN_CAP_repr	CUX1; TBX21 (directAnnotation).
CD55	metacluster_127.3	FOXO1; FOXO3; FOXO4 (directAnnotation).
CD55	metacluster_135.3	ZNF486 (directAnnotation).
CD55	metacluster_155.34	PRDM4 (directAnnotation).
CD55	metacluster_131.3	ZNF436 (inferredBy_Orthology).
CD55	metacluster_172.5	FOXD4L1; FOXD4L6 (directAnnotation). FOXD1; FOXD2; FOXD4; FOXD4L1; FOXD4L3; FOXD4L4; FOXD4L5; FOXD4L6 (inferredBy_Orthology).
CD55	transfac_pro__M04699	MAFK (directAnnotation).

Page: 1 2

Top

Acts as a transcription factor

This table shows that this differential gene acts as a transcription factor.

Top

Acts as a drug target

This table shows that this differential gene acts as a drug target.

Target name	Drug name	Drug ID	Drug type
CD55	"Chloramphenicol"	DB00446	small molecule

Page: 1

1	"Sun X, Zhang Y, Li H, Zhou Y, Shi S, Chen Z, He X, Zhang H, Li F, Yin J, Mou M, Wang Y, Qiu Y, Zhu F. DRESIS: the first comprehensive landscape of drug resistance information. Nucleic Acids Res. 2023 Jan 6;51(D1):D1263-D1275. doi: 10.1093/nar/gkac812. PMID: 36243960; PMCID: PMC9825618."
2	"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. doi: 10.1093/nar/gkx1037. PMID: 29126136; PMCID: PMC5753335."